Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07818083 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of Ruptured Intracranial Aneurysms With Stent

Name: The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of Ruptured Intracranial Aneurysms With Stent — clinical trial record (NCT07818083)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TEARIAS

StatusNot Yet Recruiting

PhasePhase 3

SponsorFirst Affiliated Hospital of Fujian Medical University

Started2026-09-01

View on ClinicalTrials.gov ↗

First Affiliated Hospital of Fujian Medical University

56 trials monitored

See all monitored trials

This multicenter prospective randomized controlled study will enroll patients with ruptured intracranial aneurysms receiving stent-assisted coiling across multiple Chinese medical centers. The investigators aim to evaluate the efficacy and safety of tirofiban-enhanced antiplatelet therapy versus conventional dual antiplatelet treatment on the 90-day neurological prognosis and major adverse cerebrovascular events of enrolled subjects.

Trial Details

NCT Number	NCT07818083
Lead Sponsor	First Affiliated Hospital of Fujian Medical University
Conditions	Ruptured Intracranial Aneurysms, Subarachnoid Hemorrhage, Aneurysmal
Enrollment	622 participants
Start Date	2026-09-01
Primary Completion	2028-09-30 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-14